Santa Cruz Biotechnology provides a broad selection of PP2A-C monoclonal antibodies for research focused on understanding protein phosphatase 2A (PP2A) in cellular processes. PP2A-C monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PP2A is a key serine/threonine phosphatase that regulates numerous cellular functions, including cell growth, division, and apoptosis. PP2A dysregulation has been implicated in various diseases, including cancer, making PP2A-C an important target for therapeutic intervention and biomarker discovery. Understanding PP2A-C dynamics plays a vital role in uncovering signaling pathways and disease mechanisms. PP2A-C monoclonal antibodies enable detailed investigation of cellular signaling networks and their impact on disease development. Researchers can leverage PP2A-C monoclonal antibodies to examine protein interactions and modifications across different cellular compartments. Santa Cruz Biotechnology monoclonal antibodies for PP2A-C support researchers worldwide in advancing scientific knowledge of cellular regulation and disease mechanisms.